These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10426650)

  • 1. Development and validation of an objective method of determining skin erythema to transdermal oestradiol patches.
    Ross D; Whitehead M; Pike B
    Br J Obstet Gynaecol; 1999 Mar; 106(3):279-83. PubMed ID: 10426650
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised crossover comparison of skin irritation with two transdermal oestradiol patches.
    Ross D; Rees M; Godfree V; Cooper A; Hart D; Kingsland C; Whitehead M
    BMJ; 1997 Aug; 315(7103):288. PubMed ID: 9274549
    [No Abstract]   [Full Text] [Related]  

  • 3. Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally.
    Boehncke WH; Gall H
    Contact Dermatitis; 1996 Sep; 35(3):187-8. PubMed ID: 8930492
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin reactions with transdermal estradiol therapy in a tropical environment.
    Bhathena RK; Anklesaria BS; Ganatra AM
    Int J Gynaecol Obstet; 1998 Feb; 60(2):177-9. PubMed ID: 9509960
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study to evaluate skin irritation and adhesion of Estradot and Climara in healthy postmenopausal women.
    Ibarra de Palacios P; Schmidt G; Sergejew T; Quebe-Fehling E; Lockhart L; Krinsky L
    Climacteric; 2002 Dec; 5(4):383-9. PubMed ID: 12626218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women.
    Sentrakul P; Chompootaweep S; Sintupak S; Tasanapradit P; Tunsaringkarn K; Dusitsin N
    Maturitas; 1991 Jun; 13(2):151-4. PubMed ID: 1833610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous reactions to transdermal therapeutic systems.
    Musel AL; Warshaw EM
    Dermatitis; 2006 Sep; 17(3):109-22. PubMed ID: 16956462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate.
    Frenkel Y; Kopernik G; Lazer S; Tugendreich D; Zmira N; Oettinger M; Tendler R; Serr DM
    Maturitas; 1994 Nov; 20(1):31-6. PubMed ID: 7877518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of irritation and sensitisation of two 50 microg/day oestrogen patches.
    Toole J; Silagy S; Maric A; Fath B; Quebe-Fehling E; Ibarra de Palacios P; Laurin L; Giguere M
    Maturitas; 2002 Dec; 43(4):257-63. PubMed ID: 12468134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis from oestradiol in oestrogen patches.
    Carmichael AJ; Foulds IS
    Contact Dermatitis; 1992 Mar; 26(3):194-5. PubMed ID: 1387059
    [No Abstract]   [Full Text] [Related]  

  • 14. OESCLIM: an advanced delivery system for HRT.
    Munoz A
    Maturitas; 1999 Nov; 33 Suppl 1():S39-47. PubMed ID: 10661614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D; Rovati LC; Giacovelli G; Setnikar I; Bottiglioni F
    Arzneimittelforschung; 2000 Mar; 50(3):293-300. PubMed ID: 10758784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal estrogen therapy.
    Connell EB
    Postgrad Med; 1997 Jun; 101(6):115-6, 122, 128-30 passim. PubMed ID: 9194869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura and 17 beta-estradiol transdermal skin patch.
    Liang R; Wong RW; Cheng IK
    Am J Hematol; 1996 Aug; 52(4):334-5. PubMed ID: 8701965
    [No Abstract]   [Full Text] [Related]  

  • 18. Menorest: technical development and pharmacokinetic profile.
    Marty JP
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S29-33. PubMed ID: 8732471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy.
    Hirvonen E; Lamberg-Allardt C; Lankinen KS; Geurts P; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():19-25. PubMed ID: 9389779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.